Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) EBT (2016 - 2025)

Sanara MedTech (SMTI) has disclosed EBT for 15 consecutive years, with $6.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT rose 4493.02% year-over-year to $6.5 million, compared with a TTM value of -$333034.0 through Sep 2025, up 94.2%, and an annual FY2024 reading of -$9.8 million, down 121.22% over the prior year.
  • EBT was $6.5 million for Q3 2025 at Sanara MedTech, up from -$1.8 million in the prior quarter.
  • Across five years, EBT topped out at $6.5 million in Q3 2025 and bottomed at -$4.2 million in Q4 2022.
  • Average EBT over 5 years is -$1.7 million, with a median of -$1.8 million recorded in 2025.
  • The sharpest move saw EBT crashed 534.05% in 2024, then soared 4493.02% in 2025.
  • Year by year, EBT stood at -$3.4 million in 2021, then dropped by 22.01% to -$4.2 million in 2022, then soared by 93.7% to -$262444.0 in 2023, then plummeted by 534.05% to -$1.7 million in 2024, then soared by 493.47% to $6.5 million in 2025.
  • Business Quant data shows EBT for SMTI at $6.5 million in Q3 2025, -$1.8 million in Q2 2025, and -$3.4 million in Q1 2025.